Introduction: Intracerebral hemorrhage (ICH) is a devastating hemorrhagic event and is associated with high mortality or severe neurological sequelae. Age-associated differences in hematoma location for nonlobar ICH are not well known. The aims of the present study were to elucidate the relationship between age and hematoma location and to assess the differences in small-vessel disease (SVD) burden as a potential surrogate marker for longstanding hypertension among various hematoma locations. Methods: From September 2014 through July 2019, consecutive patients with acute, spontaneous ICH were retrospectively enrolled from a prospective registry. Magnetic resonance imaging was performed during admission, and the total SVD burden score (including microbleeds, lacunes, enlarged perivascular spaces, and white matter hyperintensities) was calculated. The relationships of hematoma location with aging and SVD burden were assessed by using multivariate logistic regression analyses. Results: A total of 444 patients (156 women [35%]; median age 69 [interquartile range 59–79] years; National Institutes of Health Stroke Scale score 9 [17][3–17]) were enrolled in the present study. Multivariate logistic regression analyses showed that advanced age was independently associated with thalamic (odds ratio [OR]: 1.48, 95% confidence interval [CI]: 1.19–1.84, p < 0.001 for 10-year increment) and lobar hemorrhage (OR: 1.58, 95% CI: 1.19–2.09, p = 0.002) and was independently and negatively related to putaminal hemorrhage (OR: 0.55, 95% CI: 0.44–0.68, p < 0.001). The total SVD burden score was independently and positively associated with thalamic hemorrhage (OR: 1.27, 95% CI: 1.01–1.59, p = 0.045) and negatively with lobar hemorrhage (OR: 0.74, 95% CI: 0.55–0.99, p = 0.042), even after adjusting by age, but not with putaminal hemorrhage (OR: 0.91, 95% CI: 0.73–1.14, p = 0.395). Conclusion: Putaminal, thalamic, and lobar hemorrhages are prone to occur in specific ages and SVD states: putaminal in young patients, thalamic in old and high SVD burden patients, and lobar hemorrhages in old and low SVD burden patients. Susceptibility to bleeding with aging or severe SVD accumulation seems to differ considerably among brain locations.

1.
Sacco
S
,
Marini
C
,
Toni
D
,
Olivieri
L
,
Carolei
A
.
Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry
.
Stroke
.
2009
;
40
(
2
):
394
9
. .
2.
Krishnamurthi
RV
,
Feigin
VL
,
Forouzanfar
MH
,
Mensah
GA
,
Connor
M
,
Bennett
DA
,
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
.
Lancet Global Health
.
2013
;
1
:
e259
81
.
3.
Stein
M
,
Misselwitz
B
,
Hamann
GF
,
Scharbrodt
W
,
Schummer
DI
,
Oertel
MF
.
Intracerebral hemorrhage in the very old: future demographic trends of an aging population
.
Stroke
.
2012
;
43
(
4
):
1126
8
. .
4.
Arboix
A
,
Vall-Llosera
A
,
García-Eroles
L
,
Massons
J
,
Oliveres
M
,
Targa
C
.
Clinical features and functional outcome of intracerebral hemorrhage in patients aged 85 and older
.
J Am Geriatr Soc
.
2002
;
50
(
3
):
449
54
. .
5.
Inoue
Y
,
Miyashita
F
,
Minematsu
K
,
Toyoda
K
.
Clinical characteristics and outcomes of intracerebral hemorrhage in very elderly
.
J Stroke Cerebrovasc Dis
.
2018
;
27
(
1
):
97
102
. .
6.
Chiquete
E
,
Ruiz-Sandoval
MC
,
Alvarez-Palazuelos
LE
,
Padilla-Martínez
JJ
,
González-Cornejo
S
,
Ruiz-Sandoval
JL
.
Hypertensive intracerebral hemorrhage in the very elderly
.
Cerebrovasc Dis
.
2007
;
24
(
2–3
):
196
201
. .
7.
Itabashi
R
,
Yasaka
M
,
Kuwashiro
T
,
Nakagaki
H
,
Miyashita
F
,
Naritomi
H
,
Location of acute brain hemorrhage in patients undergoing antithrombotic therapy
.
J Neurol Sci
.
2009
;
280
(
1–2
):
87
9
. .
8.
Steiner
T
,
Petersson
J
,
Al-Shahi Salman
R
,
Christensen
H
,
Cordonnier
C
,
Csiba
L
,
European research priorities for intracerebral haemorrhage
.
Cerebrovasc Dis
.
2011
;
32
(
5
):
409
19
. .
9.
Forti
P
,
Maioli
F
,
Domenico Spampinato
M
,
Barbara
C
,
Nativio
V
,
Coveri
M
,
The effect of age on characteristics and mortality of intracerebral hemorrhage in the oldest-old
.
Cerebrovasc Dis
.
2016
;
42
(
5–6
):
485
92
. .
10.
Gotoh
S
,
Hata
J
,
Ninomiya
T
,
Hirakawa
Y
,
Nagata
M
,
Mukai
N
,
Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community
.
Circ J
.
2014
;
78
(
2
):
403
9
. .
11.
Hirohata
M
,
Yoshita
M
,
Ishida
C
,
Ikeda
SI
,
Tamaoka
A
,
Kuzuhara
S
,
Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy
.
Eur J Neurol
.
2010
;
17
(
6
):
823
9
. .
12.
Suzuki
K
,
Kutsuzawa
T
,
Takita
K
,
Ito
M
,
Sakamoto
T
,
Hirayama
A
,
Clinico-epidemiologic study of stroke in Akita, Japan
.
Stroke
.
1987
;
18
(
2
):
402
6
. .
13.
Delcourt
C
,
Sato
S
,
Zhang
S
,
Sandset
EC
,
Zheng
D
,
Chen
X
,
Intracerebral hemorrhage location and outcome among INTERACT2 participants
.
Neurology
.
2017
;
88
(
15
):
1408
14
. .
14.
Caplan
L
.
Intracerebral hemorrhage revisited
.
Neurology
.
1988
;
38
(
4
):
624
7
. .
15.
Furuta
A
,
Ishii
N
,
Nishihara
Y
,
Horie
A
.
Medullary arteries in aging and dementia
.
Stroke
.
1991
;
22
(
4
):
442
6
. .
16.
Pantoni
L
.
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
.
Lancet Neurol
.
2010
;
9
(
7
):
689
701
. .
17.
Hilal
S
,
Mok
V
,
Youn
YC
,
Wong
A
,
Ikram
MK
,
Chen
CL
.
Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries
.
J Neurol Neurosurg Psychiatry
.
2017
;
88
(
8
):
669
74
. .
18.
Sakamoto
Y
,
Nito
C
,
Nishiyama
Y
,
Suda
S
,
Matsumoto
N
,
Aoki
J
,
Safety of anticoagulant therapy including direct oral anticoagulants in patients with acute spontaneous intracerebral hemorrhage
.
Circ J
.
2019
;
83
(
2
):
441
6
. .
19.
Wardlaw
JM
,
Smith
EE
,
Biessels
GJ
,
Cordonnier
C
,
Fazekas
F
,
Frayne
R
,
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
.
Lancet Neurol
.
2013
;
12
(
8
):
822
38
. .
20.
Fazekas
F
,
Chawluk
JB
,
Alavi
A
,
Hurtig
HI
,
Zimmerman
RA
.
MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging
.
AJR Am J Roentgenol
.
1987
;
149
(
2
):
351
6
. .
21.
Doubal
FN
,
MacLullich
AM
,
Ferguson
KJ
,
Dennis
MS
,
Wardlaw
JM
.
Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease
.
Stroke
.
2010
;
41
(
3
):
450
4
. .
22.
Staals
J
,
Makin
SD
,
Doubal
FN
,
Dennis
MS
,
Wardlaw
JM
.
Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
.
Neurology
.
2014
;
83
(
14
):
1228
34
. .
23.
Jung
YH
,
Jang
H
,
Park
SB
,
Choe
YS
,
Park
Y
,
Kang
SH
,
Strictly lobar microbleeds reflect amyloid angiopathy regardless of cerebral and cerebellar compartments
.
Stroke
.
2020
;
51
(
12
):
3600
7
. .
24.
Graff-Radford
J
,
Botha
H
,
Rabinstein
AA
,
Gunter
JL
,
Przybelski
SA
,
Lesnick
T
,
Cerebral microbleeds: prevalence and relationship to amyloid burden
.
Neurology
.
2019
;
92
(
3
):
e253
62
. .
25.
Sreekrishnan
A
,
Dearborn
JL
,
Greer
DM
,
Shi
FD
,
Hwang
DY
,
Leasure
AC
,
Intracerebral hemorrhage location and functional outcomes of patients: a systematic literature review and meta-analysis
.
Neurocrit Care
.
2016
;
25
(
3
):
384
91
. .
26.
Itoh
Y
,
Yamada
M
,
Hayakawa
M
,
Otomo
E
,
Miyatake
T
.
Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly
.
J Neurol Sci
.
1993
;
116
(
2
):
135
41
. .
27.
Mandybur
TI
.
Cerebral amyloid angiopathy: the vascular pathology and complications
.
J Neuropathol Exp Neurol
.
1986
;
45
(
1
):
79
90
. .
28.
Blanco
PJ
,
Müller
LO
,
Spence
JD
.
Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease
.
Stroke Vasc Neurol
.
2017
;
2
(
3
):
108
17
. .
29.
Yamaguchi
T
,
Miyashita
T
,
Minematsu
K
,
Yamaguchi
S
,
Moriyasu
H
.
Incidence of thalamic infarction and hemorrhage, and their distribution in the thalamus (in Japanese with English abstract)
.
Jpn J Stroke
.
1987
;
9
:
513
8
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.